Abstract
Medulloblastoma is the most common malignant pediatric brain tumour, accounting for nearly 20% of all childhood intracranial neoplasms. It is classified as an embryonal tumour and most commonly arises in the cerebellar vermis or hemispheres of children.¹ The 2021 World Health Organisation (WHO) classification recognises medulloblastoma as a molecularly heterogeneous entity with distinct clinical and prognostic implications.¹,³
Primary extracranial or spinal medulloblastomas are exceedingly rare, with only isolated case reports and small series described in the literature.?-? Cervical spinal presentation without intracranial disease is particularly uncommon and often leads to diagnostic confusion.?







